Clinical Trial Update: A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for SHR-1210 in combination with SHR6390 in patients with advanced colorectal cancer, non-small cell lung cancer, and hepatocellular car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Hepatocellular Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• SHR-1210 (camrelizumab)
• SHR6390 (SHR6390)

Snippet

Sponsor: Harbin Medical University | Conditions: CRC, HCC | Phase 1, Phase 2 | Status: UNKNOWN